The Dermatologist’s Full-Body Skin Check Isn’t a Medicare Preventive Service. If Biopsied, the Visit Can Produce Three Bills

A 68-year-old with a lifetime of sun exposure books the annual full-body skin exam her primary care doctor suggested. She expects it to work like the yearly wellness visit: covered, no bill, done. A month later, the explanation of benefits arrives with three lines on it: an office visit, a shave biopsy of one suspicious spot, and a charge from an outside pathology lab.

She may owe on all three. She may also owe the full cost of the exam itself, which is the part nobody warns about before the appointment.

Two Facts That Get Collapsed Into One

Two things are separately true here, and the link between them is not what most people assume. The U.S. Preventive Services Task Force gives skin cancer screening in asymptomatic adults an “I” statement, meaning it found insufficient evidence to recommend for or against it. Separately, Medicare does not list routine skin cancer screening among its preventive benefits.

Both statements are accurate. Medicare’s preventive coverage is not controlled exclusively by Task Force grades, so the first does not cause the second. They are two independent reasons the skin check sits outside the preventive category. For context, skin cancer is the most commonly diagnosed cancer in the United States, which is precisely why so many primary care physicians still recommend the exam despite Medicare’s coverage gap.

The Coverage Question Comes Before the Cost-Sharing Question

The distinction that decides your bill turns on why you are in the chair. If you are asymptomatic with no relevant history, Medicare may treat the entire screening exam as noncovered. That is not deductible-and-coinsurance territory. The full charge is yours.

If the visit is diagnostic, prompted by a suspicious lesion, by symptoms, or by surveillance after a prior skin cancer, Medicare may cover it. Then the standard Part B cost-sharing applies: the $283 annual deductible if you have not met it, then 20% of the approved amount. Same exam room, same dermatologist, two very different billing outcomes.

Where the Additional Bills Come From

If the dermatologist samples a lesion, the biopsy is separately billable with its own coinsurance. The tissue goes to pathology, which may bill independently and carry its own Part B cost-sharing depending on how the service is classified.

A same-day office visit is separately payable only when the evaluation is distinct enough from the procedure to stand on its own. Three bills is a possible outcome rather than an automatic one, which is precisely why the explanation of benefits is where most patients first learn which version they got.

What It Costs in 2026

The standard Part B premium is $202.90, up from $185.00 in 2025. The annual deductible is $283, up from $257. That deductible resets every January, and dermatology appointments cluster early in the year, so a patient may be covering the full allowed amount before coinsurance engages at all. Original Medicare has no out-of-pocket maximum, so the 20% keeps applying to every covered service the visit generates.

The same billing dynamic surfaces elsewhere in Medicare. A wellness visit can produce a modest bill the moment a separate clinical issue comes up during the appointment. A screening colonoscopy is covered at no cost until a polyp is removed, at which point a 15% coinsurance applies under the current 2026 rule. That colonoscopy coinsurance is being phased down to zero by 2030 under a federal schedule, but no comparable phase-down exists for the skin exam coverage gap. Coverage gaps like this one run throughout the program, and we mapped the rest in a free guide to Medicare’s hidden bills.

What Medigap and Advantage Actually Do

Medigap Plan G covers the 20% coinsurance on the visit, the biopsy, and the pathology once the Part B deductible is met, for Medicare-covered services from providers who accept assignment. The limitation matters more than the coverage: Plan G pays cost-sharing on services Medicare covers. It cannot convert a noncovered routine screening exam into a covered benefit. If the exam falls outside Medicare’s coverage entirely, the supplement does not reach it.

Medicare Advantage enrollees face plan-specific cost-sharing at every step, and the network question has to be asked plan by plan. Some plans contract with the lab your dermatologist uses; some do not. If the lab is out of network, an HMO may not cover routine out-of-network pathology at all, while a PPO may cover it against a higher combined in-network and out-of-network maximum. There is no general rule here worth leaning on.

Go on Offense

The cheapest moment to settle coverage is before the biopsy. Take the following steps to avoid any surprise bills:

• Ask how the visit will be coded and whether Medicare is expected to cover it. If you are asymptomatic with no history, ask directly whether they anticipate billing you for a noncovered service. That is a different conversation than deductible and coinsurance. Providers are required to issue a written Advance Beneficiary Notice of Noncoverage before rendering a service they expect Medicare to deny, so receiving one before the visit is both a signal and an opening to ask questions.
• Pause before the biopsy. A dermatologist who spots something will often sample it on the spot. You can ask what the biopsy and the pathology will cost you before consenting.
• If you are on an Advantage plan, ask which lab receives the sample and confirm it participates in your network. If it does not, ask for an in-network alternative before the tissue leaves the office.

Skin cancer is serious, and suspicious or changing lesions deserve prompt evaluation. The coverage distinction should shape the budget, not discourage necessary care.

Editor’s note: This update corrects the colonoscopy polyp-removal coinsurance comparison, which now reflects the current 2026 rate of 15% (being phased to 0% by 2030) rather than the prior 20% figure, and adds context on the Advance Beneficiary Notice that providers must issue before rendering services Medicare is expected to deny.

Contact [email protected] for any questions or corrections.